Immunomodulation

Explore clinical trials studying Immunomodulation. Study availability and eligibility vary by location and protocol.

7 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Immunomodulation trial results

Not Yet Recruiting

The Role of Transcutaneous Vagus Nerve Stimulation in Treatment of Acute Brain Injury

NCT07384845

Conditions: Acute Brain Injury, Brain Diseases, Brain Injuries, +8 more
Locations: UHCZagreb Zagreb, Croatia

View Trial Details

Not Yet Recruiting

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

NCT07324473

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View Trial Details

Completed

Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections

NCT06218225

Conditions: Immunomodulation, Infections, Respiratory Tract; Infection, Upper (Acute)
Locations: Gioacchino Calapai Messina, Italy

View Trial Details

Completed

Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19

NCT05222347

Conditions: Immunomodulation
Locations: Tumosan Konya Tractor Factory Konya, Selcuklu, Turkey (Türkiye)

View Trial Details

Completed

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

NCT03107663

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +10 more
Locations: Honor Health and Imaging Endpoints Scottsdale, Arizona, United States

Memorial Sloan Kettering Cancer Center New York, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

NCT01736696

Conditions: Immunomodulation, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +5 more
Locations: Pfizer Investigational Site Little Rock, Arkansas, United States

View Trial Details

Active, Not Recruiting

ESAN III - Energy Sensing in Depression

NCT06985381

Conditions: Body Weight, Gut Microbiota Modulation, Immunomodulation, +7 more
Locations: Medical Universtiy of Graz Graz, Styria, Austria

View Trial Details

Immunomodulation

Immunomodulation trial results

The Role of Transcutaneous Vagus Nerve Stimulation in Treatment of Acute Brain Injury

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

Effect of an Immune-boosting Food Supplement on the Severity and Frequency of Pediatric Respiratory Tract Infections

Immunomodulatory and Preventive Effects of Olive Leaf Tea Against COVID-19

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis

ESAN III - Energy Sensing in Depression

Related conditions